25 Apr Novacyt raises €7.75m to complete the acquisition of Primerdesign
Posted at 05:20h
in Novacyt Group
Novacyt Primerdesign Acquisition Update PR (25-4-16) ENGLISH
Paris, France and Cambridge, UK – 25th April 2016, – Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, announces it has completed the previously announced €7.0m financing having raised a total of €7.75m. These funds will allow the Company to complete the acquisition of Primerdesign Ltd (“Primerdesign”). The Company anticipates that it will now complete the Primerdesign acquisition no later than the 12th May 2016.